Apolipoprotein E Isoform-Dependent Effects on Human Amyloid Precursor Protein/Aβ-Induced Behavioral Alterations and

Sarah Holden1, Payel Kundu1, Eileen R S Torres1

  • 1Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.

Insights

Apolipoprotein E (apoE) isoforms influence Alzheimer's disease (AD) pathology. ApoE3, but not apoE4, protected against amyloid precursor protein (APP)-induced cognitive deficits in mice, showing isoform-dependent effects on AD-related behaviors and Aβ42 levels.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder characterized by amyloid precursor protein (APP) accumulation and cognitive decline.
  • Apolipoprotein E (apoE) isoforms (E2, E3, E4) play a critical role in brain lipid transport and AD risk, with E4 increasing and E2 decreasing risk.
  • Previous studies on apoE's role in AD mouse models were limited by methodology, necessitating further investigation into isoform-specific effects.

Purpose of the Study:

  • To investigate the isoform-dependent effects of human apoE (E2, E3, E4) on behavioral alterations and cognitive impairments induced by human APP (hAPP) in mouse models.
  • To determine whether these effects are influenced by the presence of specific APP mutations (Swedish, Iberian, Arctic) and vary with age (6 and 18 months) and sex.
  • To analyze the impact of apoE isoforms on cortical insoluble amyloid-beta 42 (Aβ42) levels in these mouse models.

Main Methods:

  • Crossed transgenic mice expressing human APP mutations with mice expressing human apoE isoforms (E2, E3, E4).
  • Conducted behavioral and cognitive testing (e.g., Morris water maze) in male and female mice at 6 and 18 months of age.
  • Assessed cortical insoluble Aβ42 levels in various mouse genotypes.

Main Results:

  • Significant interactions between APP and apoE genotypes were observed, indicating apoE isoform-dependent effects on hAPP/Aβ-induced behaviors and cognition.
  • ApoE3, but not apoE2 or apoE4, demonstrated protective effects against hAPP/Aβ-induced spatial memory impairments prior to plaque pathology.
  • Specific apoE isoforms influenced cortical insoluble Aβ42 levels, with NL-G-F/E3 and NL-F/E3 mice exhibiting lower levels than NL-G-F/E4 and NL-F/E4 mice, respectively.

Conclusions:

  • Apolipoprotein E isoforms exert significant, isoform-dependent effects on behavioral and cognitive alterations associated with human APP and amyloid-beta pathology.
  • The findings highlight the differential impact of apoE isoforms on AD-related phenotypes and Aβ deposition in mouse models.
  • These results underscore the importance of considering apoE isoform status in the context of AD pathogenesis and potential therapeutic strategies.